Evidence map›Paper›PMID 42180813›Full record

ReviewAmerican journal of cardiovascular disease2026

Advancing cardiac tumor diagnosis: evaluating

Jalal Kargar, Farshad Riahi, Reza Gerami

Abstract readReview
In one paragraph

Review in American journal of cardiovascular disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jalal KargarDepartment of Radiology, School of Medicine, AJA University of Medical Sciences Tehran, Iran.
Farshad RiahiDepartment of Radiology, Isfahan University of Medical Sciences Isfahan, Iran.
Reza GeramiDepartment of Radiology, School of Medicine, AJA University of Medical Sciences Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac tumors are rare but clinically significant lesions requiring prompt and accurate diagnosis. While echocardiography remains the first-line imaging modality, it is limited by its inability to characterize tissue. Cardiovascular magnetic resonance imaging (CMR) and cardiac computed tomography (CT) offer superior anatomical detail but cannot reliably differentiate benign from malignant tumors.

methodsA systematic scoping review was conducted following a structured literature search covering January 2019 to September 2025. After screening 192 articles and applying predefined inclusion and exclusion criteria, 7 retrospective studies enrolling a total of 381 adult patients with newly diagnosed cardiac masses who underwent

resultsAcross all included studies,

conclusion

Indexed as

18F-Fluorodeoxyglucose positron emission tomography/computed tomographyCardiac tumordiagnosis

Identifiers

PMID42180813
PMCPMC13195258

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.